These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 18174452)
1. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Luo B; Soesanto Y; McClain DA Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):651-7. PubMed ID: 18174452 [TBL] [Abstract][Full Text] [Related]
2. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Vosseller K; Wells L; Lane MD; Hart GW Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983 [TBL] [Abstract][Full Text] [Related]
3. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898 [TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Park SY; Ryu J; Lee W Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877 [TBL] [Abstract][Full Text] [Related]
5. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy. Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430 [TBL] [Abstract][Full Text] [Related]
6. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Fülöp N; Marchase RB; Chatham JC Cardiovasc Res; 2007 Jan; 73(2):288-97. PubMed ID: 16970929 [TBL] [Abstract][Full Text] [Related]
7. Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus. Heath JM; Sun Y; Yuan K; Bradley WE; Litovsky S; Dell'Italia LJ; Chatham JC; Wu H; Chen Y Circ Res; 2014 Mar; 114(7):1094-102. PubMed ID: 24526702 [TBL] [Abstract][Full Text] [Related]
8. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy. Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074 [TBL] [Abstract][Full Text] [Related]
9. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250 [TBL] [Abstract][Full Text] [Related]
10. Sonic hedgehog improves ischemia-induced neovascularization by enhancing endothelial progenitor cell function in type 1 diabetes. Qin Y; He YH; Hou N; Zhang GS; Cai Y; Zhang GP; Xiao Q; He LS; Li SJ; Yi Q; Luo JD Mol Cell Endocrinol; 2016 Mar; 423():30-9. PubMed ID: 26773732 [TBL] [Abstract][Full Text] [Related]
11. Regulation of Akt signaling by O-GlcNAc in euglycemia. Soesanto YA; Luo B; Jones D; Taylor R; Gabrielsen JS; Parker G; McClain DA Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E974-80. PubMed ID: 18728220 [TBL] [Abstract][Full Text] [Related]
12. Diabetes-Induced Jagged1 Overexpression in Endothelial Cells Causes Retinal Capillary Regression in a Murine Model of Diabetes Mellitus: Insights Into Diabetic Retinopathy. Yoon CH; Choi YE; Cha YR; Koh SJ; Choi JI; Kim TW; Woo SJ; Park YB; Chae IH; Kim HS Circulation; 2016 Jul; 134(3):233-47. PubMed ID: 27407072 [TBL] [Abstract][Full Text] [Related]
13. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. Liu J; Pang Y; Chang T; Bounelis P; Chatham JC; Marchase RB J Mol Cell Cardiol; 2006 Feb; 40(2):303-12. PubMed ID: 16337959 [TBL] [Abstract][Full Text] [Related]
14. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice. Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591 [TBL] [Abstract][Full Text] [Related]
15. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. Yao D; Taguchi T; Matsumura T; Pestell R; Edelstein D; Giardino I; Suske G; Rabbani N; Thornalley PJ; Sarthy VP; Hammes HP; Brownlee M J Biol Chem; 2007 Oct; 282(42):31038-45. PubMed ID: 17670746 [TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells. Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920 [TBL] [Abstract][Full Text] [Related]
17. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells. Goldberg H; Whiteside C; Fantus IG Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532 [TBL] [Abstract][Full Text] [Related]
18. Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration. Han I; Oh ES; Kudlow JE Biochem J; 2000 Aug; 350 Pt 1(Pt 1):109-14. PubMed ID: 10926833 [TBL] [Abstract][Full Text] [Related]
19. Hexosamines, insulin resistance, and the complications of diabetes: current status. Buse MG Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923 [TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy. Dong W; Imdad L; Xu S; Wang Y; Liu C; Song S; Li Z; Kong Y; Kong L; Ren X Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]